ÇINAR, G. Et Al. 2018. Tenofovir versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/Nucleotide Analogs.. 16th European Meeting on HIV Hepatitis Treatment Strategies Antiviral Drug Resistance .

ÇINAR, G., Karadağ, Y., KADER, Ç., Korkmaz, F., Tülek, N., SÜER, H. K., ... BATIREL, A.(2018). Tenofovir versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/Nucleotide Analogs. . 16th European Meeting on HIV Hepatitis Treatment Strategies Antiviral Drug Resistance

ÇINAR, GÜLE Et Al. "Tenofovir versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/Nucleotide Analogs.," 16th European Meeting on HIV Hepatitis Treatment Strategies Antiviral Drug Resistance, 2018

ÇINAR, GÜLE Et Al. "Tenofovir versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/Nucleotide Analogs.." 16th European Meeting on HIV Hepatitis Treatment Strategies Antiviral Drug Resistance , 2018

ÇINAR, G. Et Al. (2018) . "Tenofovir versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/Nucleotide Analogs.." 16th European Meeting on HIV Hepatitis Treatment Strategies Antiviral Drug Resistance .

@conferencepaper{conferencepaper, author={GÜLE ÇINAR Et Al. }, title={Tenofovir versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients with Poor Efficacy of Nucleoside/Nucleotide Analogs.}, congress name={16th European Meeting on HIV Hepatitis Treatment Strategies Antiviral Drug Resistance}, city={}, country={}, year={2018}}